Public disclosure
FY 2017-18 - Q3
- FHPL
- Health India
- MD India
- PHS
- Vidal
- UPHC
- NL-1 Revenue Account
- NL-2 Profit and Loss Account
- NL-3 Balance Sheet
- NL-4 Premium
- NL-5 Claims Incurred
- NL-6 Commission
- NL-7 Operating Expenses
- NL-8 Share Capital
- NL-9 Pattern of Shareholding
- NL-9A Pattern of Shareholding-Annexure A
- NL-10 Reserves and Surplus
- NL-11 Borrowings
- NL-12 & 12A Investments
- NL-13 Loans
- NL-14 Fixed Assets
- NL-15 Cash and Bank Balance
- NL-16 Advances & Other Assets
- NL-17 Current Liabilities
- NL-18 Provisions
- NL-19 Misc Expenditure
- NL-20 Analytical Ratios
- NL-21 Related Party Transactions
- NL-23 Statement of Admissible Assets
- NL-24 Statement of Liabilities
- NL-25 Required Solvency Margin
- NL-26 Solvency Margin
- NL-21 Statement of Liabilities_Q3
- NL-22 Geographical Distribution of Business
- NL-23 Reinsurance Risk Concentration
- NL-24 Ageing of Claims
- NL-25 Quarterly Claims Data
- NL-26 Claims Information
- NL-27 Offices
- NL-28 Statement of Assets
- NL-29 Debt Securities
- NL-30 Analytical Ratios
- NL-31 Related Party
- NL-32 Product Information
- NL-33 Solvency
- NL-34 Board of Directors and Mangement
- NL-35 NPAs
- NL-36 Yield on Investments
- NL-37 Downgrading of Investments
- NL-38 Quarterly Business Returns of different business
- NL-39 Rural & Social Sector Obligations
- NL-40 Business Acquisition through different channels
- NL-41 Grievance Disposal
FY 2017-18 - Q4
- FHPL
- Health India
- MD India
- PHS
- UPHC
- Vidal
- NL-1 Revenue Accounts
- NL-2 Profit & Loss Account
- NL-3 Balance Sheet
- NL-4 Premium Earned
- NL-5 Claims Incurred
- NL-6 Commission
- NL-7 Operating Expenses
- NL-8 Share Capital
- NL-9 Shareholding Pattern
- NL-10 Reserves and Surplus
- NL-11 Borrowings
- NL-12 Investments_Q4
- NL-13 Loans
- NL-14 Fixed Assets
- NL-15 Cash and Bank balances
- NL-16 Advances and Other Assets
- NL-17 Current Liabilities
- NL-18 Provisions
- NL-19 Misc Expenditure
- NL-20 Receipt & Payments
- NL-21 Statement of Liabilities
- NL-22 Geographical Distribution of Business
- NL-23 Reinsurance Risk Concentration
- NL-24 Ageing of Claims
- NL-25 Quarterly Claims data
- NL-26 Claims Information
- NL-27 Offices
- NL-28 Statement of Assets
- NL-29 Debt Securities
- NL-30 Analytical Ratios
- NL-31 Related Party
- NL-32 Product Information
- NL-33 Solvency
- NL-34 Board of Directors and Mangement
- NL-35 NPAs
- NL-36 Yield on Investments
- NL-37 Downgrading of Investments
- NL-38 Quarterly Business Returns of different business
- NL-39 Rural & Social Sector Obligations
- NL-40 Business Acquisition through different channels
- NL-41 Grievance Disposal
- FHPL
- Medi Assist
FY 2018-19 - Q1
- Health India
- MD India
- PHS
- UPHC
- Vidal_Q1
- NL-1 Revenue Accounts
- NL-2 Profit & Loss Account
- NL-3 Balance Sheet
- NL-4 Premium Earned
- NL-5 Claims Incurred
- NL-6 Commission
- NL-7 Operating Expenses
- NL-8 Share Capital
- NL-9 Shareholding Pattern
- NL-10 Reserves and Surplus
- NL-11 Borrowings
- NL-12 Investments
- NL-13 Loans
- NL-14 Fixed Assets
- NL-15 Cash and Bank Balances
- NL-16 Advances and Other Assets
- NL-17 Current Liabilities
- NL-18 Provisions
- NL-19 Misc Expenditure
- NL-20 Receipt and Payments
- NL-21 Statement of Liabilities
- NL-22 Geographical Distribution of Business
- NL-23 Reinsurance Risk Concentration
- NL-24 Ageing of Claims
- NL-25 Quarterly Claims Data
- NL-26 Claims Information
- NL-27 Offices
- NL-28 Statement of Assets
- NL-29 Debt Securities
- NL-30 Analytical Ratios
- NL-31 Related Party
- NL-32 Product Information
- NL-33 Solvency
- NL-34 Board of Directors and Mangement
- NL-35 NPAs
- NL-36 Yield on Investments
- NL-37 Downgrading of Investments
- NL-38 Quarterly Business Returns of different business
- NL-39 Rural & Social Sector Obligations
- NL-40 Business Acquisition through different channels
- NL-41 Grievance Disposal
FY 2018-19 - Q2
- Health India
- MD India
- PHS
- UPHC
- Vidal
- NL-1 Revenue Accounts (1)
- NL-2 Profit & Loss Account
- NL-3 Balance Sheet
- NL-4 Premium Earned
- NL-5 Claims Incurred
- NL-6 Commission
- NL-7 Operating Expenses
- NL-8 Share Capital
- NL-9 Shareholding Pattern
- NL-10 Reserves and Surplus
- NL-11 Borrowings
- NL-12 Investments
- NL-13 Loans
- NL-14 Fixed Assets
- NL-15 Cash and Bank Balances
- NL-16 Advances and Other Assets
- NL-17 Current Liabilities
- NL-18 Provisions
- NL-19 Misc Expenditure
- NL-20 Receipt and Payments
- NL-20 Receipt and Payments
- NL-21 Statement of Liabilities
- NL-22 Geographical Distribution of Business
- NL-23 Reinsurance Risk Concentration
- NL-24 Ageing of Claims_Q2_Sep2018_FY2018-19
- NL-25 Quarterly Claims Data_H1_Sep2018_FY2018-19
- NL-26 Claims Information
- NL-27 Offices
- NL-28 Statement of Assets
- NL-29 Debt Securities
- NL-30 Analytical Ratios
- NL-31 Related Party
- NL-32 Product Information
- NL-35 NPAs
- NL-36 Yield on Investments
- NL-37 Downgrading of Investments
- NL-38 Quarterly Business Returns of different business
- NL-39 Rural & Social Sector Obligations
- NL-40 Business Acquisition through different channels
- NL-41 Grievance Disposal
FY 2018-19 - Q3
- Health India
- MD India
- PHS
- UPHC
- Vidal
- NL-1 Revenue Accounts
- NL-2 Profit & Loss Account
- NL-3 Balance Sheet
- NL-4 Premium Earned
- NL-5 Claims Incurred
- NL-6 Commission
- NL-7 Operating Expenses
- NL-8 Share Capital
- NL-9 Shareholding Pattern
- NL-10 Reserves and Surplus
- NL-11 Borrowings
- NL-12 Investments
- NL-13 Loans
- NL-14 Fixed Assets
- NL-15 Cash and Bank Balances
- NL-16 Advances and Other Assets
- NL-17 Current Liabilities
- NL-18 Provisions
- NL-19 Misc Expenditure
- NL-20 Receipt and Payments
- NL-21 Statement of Liabilities_Q3
- NL-22 Geographical Distribution of Business
- NL-23 Reinsurance Risk Concentration
- NL-24 Ageing of Claims_9M_Dec2018_FY2018-19
- NL-25 Quarterly Claims Data_9M_Dec2018_FY2018-19
- NL-26 Claims Information
- NL-27 Offices
- NL-28 Statement of Assets
- NL-29 Debt Securities
- NL-30 Analytical Ratios
- NL-31 Related Party
- NL-32 Product Information
- NL-33 Solvency
- NL-34 Board of Directors and Mangement
- NL-35 NPAs
- NL-36 Yield on Investments
- NL-37 Downgrading of Investments
- NL-38 Quarterly Business Returns of different business
- NL-39 Rural & Social Sector Obligations
- NL-40 Business Acquisition through different channels
- NL-41 Grievance Disposal
FY 2018-19 - Q4
- Health India
- MD India
- PHS
- UPHC
- Vidal
- NL-1 Revenue Accounts
- NL-2 Profit & Loss Account
- NL-3 Balance Sheet
- NL-4 Premium Earned
- NL-5 Claims Incurred
- NL-6 Commission
- NL-7 Operating Expenses
- NL-8 Share Capital
- NL-9 Shareholding Pattern
- NL-10 Reserves and Surplus
- NL-11 Borrowings
- NL-12 Investments
- NL-13 Loans
- NL-14 Fixed Assets
- NL-15 Cash and Bank Balances
- NL-16 Advances and Other Assets
- NL-17 Current Liabilities
- NL-18 Provisions
- NL-19 Misc Expenditure
- NL-20 Receipt & Payments
- NL-21 Statement of Liabilities
- NL-22 Geographical Distribution of Business
- NL-23 Reinsurance Risk Concentration
- NL-24 Ageing of Claims_Q4_Mar2019_FY2018-19
- NL-25 Quarterly Claims Data_Q4_Mar2019_FY2018-19
- NL-26 Claims Information
- NL-27 Offices
- NL-28 Statement of Assets
- NL-29 Debt Securities
- NL-30 Analytical Ratios
- NL-31 Related_Party
- NL-32 Product Information
- NL-33 Solvency
- NL-34 Board of Directors and Mangement
- NL-35 NPAs
- NL-36 Yield on Investments
- NL-37 Downgrading of Investments
- NL-38 Quarterly Business Returns of different business
- NL-39 Rural & Social Sector Obligations
- NL-40 Business Acquisition through different channels
- NL-41 Grievance Disposal
FY 2019-20 - Q1
- Health India
- MD India
- PHS
- UPHC
- Vidal
- NL-1 Revenue Accounts
- NL-2 Profit & Loss Account
- NL-3 Balance Sheet
- NL-4 Premium Earned
- NL-5 Claims Incurred
- NL-6 Commission
- NL-7 Operating Expenses
- NL-8 Share Capital
- NL-9 Shareholding Pattern
- NL-10 Reserves and Surplus
- NL-11 Borrowings
- NL-12 Investments
- NL-13 Loans
- NL-14 Fixed Assets
- NL-15 Cash and Bank Balances
- NL-16 Advances and Other Assets
- NL-17 Current Liabilities
- NL-18 Provisions
- NL-19 Misc Expenditure
- NL-20 Receipt and Payments
- NL-21 Statement of Liabilities
- NL-22 Geographical Distribution of Business
- NL-23 Reinsurance Risk Concentration
- NL-24 Ageing of Claims_Q1_Jun2019_FY2019-20
- NL-25 Quarterly Claims Data_Q1_Jun2019_FY2019-20
- NL-26 Claims Information
- NL-27 Offices
- NL-28 Statement of Assets
- NL-29 Debt Securities
- NL-30 Analytical Ratios
- NL-31 Related Party
- NL-32 Product Information
- NL-33 Solvency_Q1
- NL-34 Board of Directors and Mangement
- NL-35 NPAs
- NL-36 Yield on Investments
- NL-37 Downgrading of Investments
- NL-38 Quarterly Business Returns of different business
- NL-39 Rural & Social Sector Obligations
- NL-40 Business Acquisition through different channels
- NL-41 Grievance Disposal
FY 2019-20 - Q2
- Health India
- MD India
- PHS
- UPHC
- Vidal
- NL-1 Revenue Accounts
- NL-2 Profit & Loss Account
- NL-3 Balance Sheet
- NL-4 Premium Earned
- NL-5 Claims Incurred
- NL-6 Commission
- NL-7 Operating Expenses
- NL-8 Share Capital
- NL-9 Shareholding Pattern
- NL-10 Reserves and Surplus
- NL-11 Borrowings
- NL-12 Investments
- NL-13 Loans
- NL-14 Fixed Assets
- NL-15 Cash and Bank Balances
- NL-16 Advances and Other Assets
- NL-17 Current Liabilities
- NL-18 Provisions
- NL-19 Misc Expenditure
- NL-20 Receipt and Payments
- NL-21 Statement of Liabilities
- NL-22 Geographical Distribution of Business
- NL-23 Reinsurance Risk Concentration_H1_Sep2019_FY2019-20
- NL-24 Ageing of Claims_H1_Sep2019_FY2019-20
- NL-25 Quarterly Claims Data_H1_Sep2019_FY2019-20
- NL-26 Claims Information
- NL-27 Offices
- NL-28 Statement of Assets
- NL-29 Debt Securities
- NL-30 Analytical Ratios
- NL-31 Related Party
- NL-32 Product Information
- NL-33 Solvency
- NL-34 Board of Directors and Mangement
- NL-35 NPAs
- NL-36 Yield on Investments
- NL-37 Downgrading of Investments
- NL-38 Quarterly Business Returns of different business
- NL-39 Rural & Social Sector Obligations
- NL-40 Business Acquisition through different channels
- NL-41 Grievance Disposal
FY 2019-20 - Q3
- Health India
- MD India
- PHS
- UPHC
- Vidal
- NL-1 Revenue Accounts
- NL-2 Profit & Loss Account
- NL-3 Balance Sheet
- NL-4 Premium Earned
- NL-5 Claims Incurred
- NL-6 Commission
- NL-7 Operating Expenses
- NL-8 Share Capital
- NL-9 Shareholding Pattern
- NL-10 Reserves and Surplus
- NL-11 Borrowings
- NL-12 Investments
- NL-13 Loans
- NL-14 Fixed Assets
- NL-15 Cash and Bank Balances
- NL-16 Advances and Other Assets
- NL-17 Current Liabilities
- NL-18 Provisions
- NL-20 Receipt and Payments
- NL-21 Statement of Liabilities
- NL-22 Geographical Distribution of Business
- NL-23 Reinsurance Risk Concentration
- NL-24 Ageing of Claims
- NL-25 Quarterly Claims Data
- NL-26 Claims Information
- NL-27 Offices
- NL-28 Statement of Assets
- NL-29 Debt Securities
- NL-30 Analytical Ratios
- NL-31 Related Party
- NL-32 Product Information
- NL-33 Solvency
- NL-34 Board of Directors and Mangement
- NL-35 NPAs
- NL-36 Yield on Investments
- NL-37 Downgrading of Investments
- NL-38 Quarterly Business Returns of different business
- NL-39 Rural & Social Sector Obligations
- NL-40 Business Acquisition through different channels
- NL-41 Grievance Disposal
FY 2019-20 - Q4
- Health India
- MD India
- PHS
- UPHC
- Vidal
- NL-1 Revenue Accounts
- NL-2 Profit & Loss Account
- NL-3 Balance Sheet
- NL-4 Premium Earned
- NL-5 Claims Incurred
- NL-6 Commission
- NL-7 Operating Expenses
- NL-8 Share Capital
- NL-9 Shareholding Pattern
- NL-10 Reserves and Surplus
- NL-11 Borrowings
- NL-12 Investments
- NL-13 Loans
- NL-14 Fixed Assets
- NL-15 Cash and Bank Balances
- NL-16 Advances and Other Assets
- NL-17 Current Liabilities
- NL-18 Provisions
- NL-19 Misc Expenditure
- NL-20 Receipt & Payments
- NL-21 Statement of Liabilities
- NL-22 Geographical Distribution of Business
- NL-23 Reinsurance Risk Concentration
- NL-24 Ageing of Claims
- NL-25 Quarterly Claims Data
- NL-26 Claims Information
- NL-28 Statement of Assets
- NL-29 Debt Securities
- NL-30 Analytical Ratios
- NL-31 Related Party
- NL-32 Product Information
- NL-33 Solvency
- NL-34 Board of Directors and Mangement
- NL-35 NPAs
- NL-36 Yield on Investments
- NL-37 Downgrading of Investments
- NL-38 Quarterly Business Returns of different business
- NL-39 Rural & Social Sector Obligations
- NL-40 Business Acquisition through different channels
- NL-41 Grievance Disposal
FY 2020-21 - Q1
- Health India
- MD India
- PHS
- UPHC
- Vidal
- NL-1 Revenue Accounts
- NL-2 Profit & Loss Account
- NL-3 Balance Sheet
- NL-4 Premium Earned
- NL-5 Claims Incurred
- NL-6 Commission
- NL-7 Operating Expenses
- NL-8 Share Capital
- NL-9 Shareholding Pattern
- NL-10 Reserves and Surplus
- NL-11 Borrowings
- NL-12 Investments
- NL-13 Loans
- NL-14 Fixed Assets
- NL-15 Cash and Bank Balances
- NL-16 Advances and Other Assets
- NL-17 Current Liabilities
- NL-18 Provisions
- NL-19 Misc Expenditure
- NL-20 Receipt and Payments
- NL-21 Statement of Liabilities
- NL-22 Geographical Distribution of Business
- NL-23 Reinsurance Risk Concentration
- NL-24 Ageing of Claims
- NL-25 Quarterly Claims Data
- NL-26 Claims Information
- NL-27 Offices
- NL-28 Statement of Assets
- NL-29 Debt Securities
- NL-30 Analytical Ratios
- NL-31 Related Party
- NL-32 Product Information
- NL-34 Board of Directors and Mangement
- NL-35 NPAs
- NL-36 Yield on Investments
- NL-37 Downgrading of Investments
- NL-38 Quarterly Business Returns of different business
- NL-39 Rural & Social Sector Obligations
- NL-40 Business Acquisition through different channels
- NL-41 Grievance Disposal
FY 2020-21 - Q2
- Health India
- MD India
- PHS
- UPHC
- Vidal
- NL-1 Revenue Accounts
- NL-2 Profit & Loss Account
- NL-3 Balance Sheet
- NL-4 Premium Earned
- NL-5 Claims Incurred
- NL-6 Commission
- NL-7 Operating Expenses
- NL-8 Share Capital
- NL-9 Shareholding Pattern
- NL-10 Reserves and Surplus
- NL-11 Borrowings
- NL-12 Investments
- NL-13 Loans
- NL-14 Fixed Assets
- NL-15 Cash and Bank Balances
- NL-16 Advances and Other Assets
- NL-17 Current Liabilities
- NL-18 Provisions
- NL-19 Misc Expenditure
- NL-20 Receipt and Payments
- NL-21 Statement of Liabilities
- NL-22 Geographical Distribution of Business
- NL-24 Ageing of Claims
- NL-25 Quarterly Claims Data
- NL-26 Claims Information
- NL-27 Offices
- NL-28 Statement of Assets
- NL-29 Debt Securities
- NL-30 Analytical Ratios
- NL-31 Related Party
- NL-32 Product Information
- NL-34 Board of Directors and Mangement
- NL-35 NPAs
- NL-36 Yield on Investments
- NL-37 Downgrading of Investments
- NL-38 Quarterly Business Returns of different business
- NL-39 Rural & Social Sector Obligations
- NL-40 Business Acquisition through different channels
- NL-41 Grievance Disposal
FY 2020-21 - Q3
- Health India
- MD India
- PHS
- UPHC
- Vidal
- NL-1 Revenue Accounts
- NL-2 Profit & Loss Account
- NL-3 Balance Sheet
- NL-4 Premium Earned
- NL-5 Claims Incurred
- NL-6 Commission
- NL-7 Operating Expenses
- NL-8 Share Capital
- NL-9 Shareholding Pattern
- NL-10 Reserves and Surplus
- NL-11 Borrowings
- NL-12 Investments
- NL-13 Loans
- NL-14 Fixed Assets
- NL-15 Cash and Bank Balances
- NL-16 Advances and Other Assets
- NL-17 Current Liabilities
- NL-18 Provisions
- NL-19 Misc Expenditure
- NL-20 Receipt and Payments
- NL-21 Statement of Liabilities
- NL-22 Geographical Distribution of Business
- NL-23 Reinsurance Risk Concentration
- NL-24 Ageing of Claims
- NL-25 Quarterly Claims Data
- NL-26 Claims Information
- NL-27 Offices
- NL-28 Statement of Assets
- NL-29 Debt Securities
- NL-30 Analytical Ratios
- NL-31 Related Party
- NL-32 Product Information
- NL-33 Solvency
- NL-34 Board of Directors and Mangement
- NL-35 NPAs
- NL-36 Yield on Investments
- NL-37 Downgrading of Investments
- NL-38 Quarterly Business Returns of different business
- NL-39 Rural & Social Sector Obligations
- NL-40 Business Acquisition through different channels
- NL-41 Grievance Disposal
FY 2020-21 - Q4
- Health India
- MD India
- PHS
- UPHC
- Vidal
- NL-1 Revenue Accounts
- NL-2 Profit & Loss Account
- NL-3 Balance Sheet
- NL-4 Premium Earned
- NL-5 Claims Incurred
- NL-6 Commission
- NL-7 Operating Expenses
- NL-8 Share Capital
- NL-9 Shareholding Pattern
- NL-10 Reserves and Surplus
- NL-11 Borrowings
- NL-12 Investments
- NL-13 Loans
- NL-14 Fixed Assets
- NL-15 Cash and Bank Balances
- NL-16 Advances and Other Assets
- NL-17 Current Liabilities
- NL-18 Provisions
- NL-19 Misc Expenditure
- NL-20 Receipt & Payments
- NL-21 Statement of Liabilities
- NL-22 Geographical Distribution of Business
- NL-23 Reinsurance Risk Concentration
- NL-24 Ageing of Claims
- NL-25 Quarterly Claims Data
- NL-26 Claims Information
- NL-27 Offices
- NL-28 Statement of Assets
- NL-29 Debt Securities
- NL-30 Analytical Ratios
- NL-31 Related Party
- NL-32 Product Information
- NL-33 Solvency
- NL-34 Board of Directors and Mangement
- NL-35 NPAs
- NL-36 Yield on Investments
- NL-37 Downgrading of Investments
- NL-38 Quarterly Business Returns of different business
- NL-39 Rural & Social Sector Obligations
- NL-40 Business Acquisition through different channels
- NL-41 Grievance Disposal
FY 2021-22 - Q1
- UPHC
- Health India
- MD India
- PHS
- Vidal
- NL-1 Revenue Accounts
- NL-2 Profit & Loss Account
- NL-3 Balance Sheet
- NL-4 Premium Earned
- NL-5 Claims Incurred
- NL-6 Commission
- NL-7 Operating Expenses
- NL-8 Share Capital
- NL-9 Shareholding Pattern
- NL-10 Reserves and Surplus
- NL-11 Borrowings
- NL-12 Investments
- NL-13 Loans
- NL-14 Fixed Assets
- NL-15 Cash and Bank Balances
- NL-16 Advances and Other Assets
- NL-17 Current Liabilities
- NL-18 Provisions
- NL-19 Misc Expenditure
- NL-20 Receipt and Payments
- NL-21 Statement of Liabilities
- NL-22 Geographical Distribution of Business
- NL-23 Reinsurance Risk Concentration
- NL-24 Ageing of Claims
- NL-25 Quarterly Claims Data
- NL-26 Claims Information
- NL-27 Offices
- NL-28 Statement of Assets
- NL-29 Debt Securities
- NL-30 Analytical Ratios
- NL-31 Related Party
- NL-32 Product Information
- NL-33 Solvency
- NL-34 Board of Directors and Mangement
- NL-35 NPAs
- NL-36 Yield on Investments
- NL-37 Downgrading of Investments
- NL-38 Quarterly Business Returns of different business
- NL-39 Rural & Social Sector Obligations
- NL-40 Business Acquisition through different channels
- NL-41 Grievance Disposal
FY 2021-22 - Q2
- Health India
- MD India
- PHS
- UPHC
- Vidal
- NL-1 Revenue Account
- NL-2 Profit and Loss Account
- NL-3 Balance Sheet
- NL-4 Premium
- NL-5 Claims Incurred
- NL-6 Commission
- NL-7 Operating Expenses
- NL-8 Share Capital
- NL-9 Pattern of Shareholding
- NL-9A Pattern of Shareholding-Annexure A
- NL-10 Reserves and Surplus
- NL-11 Borrowings
- NL-12 & 12A Investments
- NL-13 Loans
- NL-14 Fixed Assets
- NL-15 Cash and Bank Balance
- NL-16 Advances & Other Assets
- NL-17 Current Liabilities
- NL-18 Provisions
- NL-19 Misc Expenditure
- NL-20 Analytical Ratios
- NL-21 Related Party Transactions
- NL-23 Statement of Admissible Assets
- NL-24 Statement of Liabilities
- NL-25 Required Solvency Margin
- NL-26 Solvency Margin
- NL-27 Product Information
- NL-28 Investment assets and Accretion of Assets
- NL-29 Debt Securities
- NL-30 Non performing assets
- NL-31 Investment and Investment Income
- NL-32 Down graded Investments
- NL-33 Reinsurance Risk Concentration
- NL-34 Geographical Distribution of Business
- NL-35 Quarterly Business Returns
- NL-36 Business channels
- NL-37 Claims Data
- NL-39 Ageing of Claims
- NL-40 Segmental Underwriting Performance
- NL-41 Office Information
- NL-42 Board of Directors & Management Person
- NL-43 Rural & Social Sector Obligations
- NL-44 Motor Third Party Obligation
- NL-45 Grievance Disposal
- NL-46 Voting Activity disclosure under Stewardship Code
FY 2021-22 - Q3
- Health India
- MD India
- PHS
- UPHC_Q3
- Vidal
- NL-1 Revenue Account
- NL-2 Profit and Loss Account
- NL-3 Balance Sheet
- NL-4 Premium
- NL-5 Claims Incurred
- NL-6 Commission
- NL-7 Operating Expenses
- NL-8 Share Capital
- NL-9 Pattern of Shareholding
- NL-9A Pattern of Shareholding-Annexure A
- NL-10 Reserves and Surplus
- NL-11 Borrowings
- NL-12 & 12A Investments
- NL-13 Loans
- NL-14 Fixed Assets
- NL-15 Cash and Bank Balance
- NL-16 Advances & Other Assets
- NL-17 Current Liabilities
- NL-18 Provisions
- NL-19 Misc Expenditure
- NL-20 Analytical Ratios
- NL-21 Related Party Transactions
- NL-23 Statement of Admissible Assets
- NL-24 Statement of Liabilities
- NL-25 Required Solvency Margin
- NL-26 Solvency Margin
- NL-27 Product Information
- NL-28 Investment assets and Accretion of Assets
- NL-29 Debt Securities
- NL-30 Non performing assets
- NL-31 Investment and Investment Income
- NL-32 Down graded Investments
- NL-33 Reinsurance Risk Concentration
- NL-34 Geographical Distribution of Business
- NL-35 Quarterly Business Returns
- NL-36 Business channels
- NL-37 Claims Data
- NL-39 Ageing of Claims
- NL-40 Segmental Underwriting Performance
- NL-41 Office Information
- NL-42 Board of Directors & Management Person
- NL-43 Rural & Social Sector Obligations
- NL-44 Motor Third Party Obligation
- NL-45 Grievance Disposal
- NL-46 Voting Activity disclosure under Stewardship Code
FY 2021-22 - Q4
- Health India
- MD India
- PHS
- UPHC
- Vidal
- NL-1 Revenue Account
- NL-2 Profit and Loss Account
- NL-3 Balance Sheet
- NL-4 Premium
- NL-5 Claims Incurred
- NL-6 Commission
- NL-7 Operating Expenses
- NL-8 Share Capital
- NL-9 Pattern of Shareholding
- NL-9A Pattern of Shareholding-Annexure A
- NL-10 Reserves and Surplus
- NL-11 Borrowings
- NL-12 & 12A Investments
- NL-13 Loans
- NL-14 Fixed Assets
- NL-15 Cash and Bank Balance
- NL-16 Advances & Other Assets
- NL-17 Current Liabilities
- NL-18 Provisions
- NL-19 Misc Expenditure
- NL-20 Analytical Ratios
- NL-21 Related Party Transactions
- NL-22 Receipts & Payment Sch
- NL-23 Statement of Admissible Assets
- NL-24 Statement of Liabilities
- NL-25 Required Solvency Margin
- NL-26 Solvency Margin
- NL-27 Product Information
- NL-28 Investment assets and Accretion of Assets
- NL-29 Debt Securities
- NL-30 Non performing assets
- NL-31 Investment and Investment Income
- NL-32 Down graded Investments
- NL-33 Reinsurance Risk Concentration
- NL-34 Geographical Distribution of Business
- NL-35 Quarterly Business Returns
- NL-36 Business channels
- NL-37 Claims Data
- NL-38 Development of Losses
- NL-39 Ageing of Claims
- NL-40 Segmental Underwriting Performance
- NL-41 Office Information
- NL-42 Board of Directors & Management Person
- NL-43 Rural & Social Sector Obligations
- NL-44 Motor Third Party Obligation
- NL-45 Grievance Disposal
- NL-46 Voting Activity disclosure under Stewardship Code
- NL-47 Performance HI PA TI
- NL-48 Health Services
- FHPL NL 48
- GHPL NL 48
- HealthIndia NL 48
- MD India NL 48
- PHS_Public Disclosure_EGIL
- Vidal NL 48
FY 2022-23 - Q1
- Health India
- MD India
- PHS
- UPHC
- Vidal
- NL-1 Revenue Account
- NL-2 Profit and Loss Account
- NL-3 Balance Sheet
- NL-4 Premium
- NL-5 Claims Incurred
- NL-6 Commission
- NL-7 Operating Expenses
- NL-8 Share Capital
- NL-9 Pattern of Shareholding
- NL-9A Pattern of Shareholding-Annexure A
- NL-10 Reserves and Surplus
- NL-11 Borrowings
- NL-12 & 12A Investments
- NL-13 Loans
- NL-14 Fixed Assets
- NL-15 Cash and Bank Balance
- NL-16 Advances & Other Assets
- NL-17 Current Liabilities
- NL-18 Provisions
- NL-19 Misc Expenditure
- NL-20 Analytical Ratios
- NL-21 Related Party Transactions
- NL-23 Statement of Admissible Assets
- NL-24 Statement of Liabilities
- NL-25 Required Solvency Margin
- NL-26 Solvency Margin
- NL-27 Product Information
- NL-28 Investment assets and Accretion of Assets
- NL-29 Debt Securities
- NL-30 Non performing assets
- NL-31 Investment and Investment Income
- NL-32 Down graded Investments
- NL-33 Reinsurance Risk Concentration
- NL-34 Geographical Distribution of Business
- NL-35 Quarterly Business Returns
- NL-36 Business channels
- NL-37 Claims Data
- NL-39 Ageing of Claims
- NL-41 Office Information
- NL-42 Board of Directors & Management Person
- NL-43 Rural & Social Sector Obligations
- NL-44 Motor Third Party Obligation
- NL-45 Grievance Disposal
- NL-46 Voting Activity disclosure under Stewardship Code
- FHPL
- Health India
- MD India
- Medi Assist
- PHS
- UPHC
- Vidal
FY 2022-23 - Q2
- Health India
- MD India
- PHS
- UPHC
- Vidal
- NL-1 Revenue Account
- NL-2 Profit and Loss Account
- NL-3 Balance Sheet
- NL-4 Premium
- NL-5 Claims Incurred
- NL-6 Commission
- NL-7 Operating Expenses
- NL-8 Share Capital
- NL-9 Pattern of Shareholding
- NL-10 Reserves and Surplus
- NL-11 Borrowings
- NL-12 & 12A Investments
- NL-13 Loans
- NL-14 Fixed Assets
- NL-15 Cash and Bank Balance
- NL-16 Advances & Other Assets_Q2
- NL-17 Current Liabilities
- NL-18 Provisions
- NL-19 Misc Expenditure
- NL-20 Analytical Ratios
- NL-21 Related Party Transactions
- NL-23 Statement of Admissible Assets
- NL-24 Statement of Liabilities
- NL-25 Required Solvency Margin
- NL-26 Solvency Margin
- NL-27 Product Information
- NL-28 Investment assets and Accretion of Assets
- NL-29 Debt Securities
- NL-30 Non performing assets
- NL-31 Investment and Investment Income
- NL-32 Down graded Investments
- NL-33 Reinsurance Risk Concentration
- NL-34 Geographical Distribution of Business
- NL-35 Quarterly Business Returns
- NL-36 Business channels
- NL-37 Claims Data
- NL-41 Office Information
- NL-42 Board of Directors & Management Person
- NL-43 Rural & Social Sector Obligations
- NL-44 Motor Third Party Obligation
- NL-45 Grievance Disposal
- NL-46 Voting Activity disclosure under Stewardship Code
- FHPL
- Medi Assist
FY 2022-23 - Q3
- NL-1 Revenue Account
- NL-2 Profit and Loss Account
- NL-3 Balance Sheet
- NL-4 Premium
- NL-5 Claims Incurred
- NL-6 Commission
- NL-7 Operating Expenses_Q3
- NL-8 Share Capital
- NL-9 Pattern of Shareholding
- NL-9A Pattern of Shareholding-Annexure A
- NL-10 Reserves and Surplus
- NL-11 Borrowings
- NL-12 & 12A Investments
- NL-13 Loans
- NL-14 Fixed Assets
- NL-15 Cash and Bank Balance
- NL-16 Advances & Other Assets
- NL-17 Current Liabilities
- NL-18 Provisions
- NL-19 Misc Expenditure
- NL-20 Analytical Ratios
- NL-21 Related Party Transactions
- NL-23 Statement of Admissible Assets
- NL-24 Statement of Liabilities
- NL-25 Required Solvency Margin
- NL-26 Solvency Margin
- NL-27 Product Information
- NL-28 Investment assets and Accretion of Assets
- NL-29 Debt Securities
- NL-30 Non performing assets
- NL-31 Investment and Investment Income
- NL-32 Down graded Investments
- NL-33 Reinsurance Risk Concentration
- NL-34 Geographical Distribution of Business
- NL-35 Quarterly Business Returns
- NL- 36 Business channels
- NL-37 Claims Data
- NL-39 Ageing of Claims
- NL-41 Office Information
- NL-42 Board of Directors & Management Person
- NL-43 Rural & Social Sector Obligations
- NL-44 Motor Third Party Obligation
- NL-45 Grievance Disposal
- NL-46 Voting Activity disclosure under Stewardship Code
FY 2022-23 - Q4
- NL-1 Revenue Account
- NL-2 Profit and Loss Account
- NL-3 Balance Sheet
- NL-4 Premium
- NL-5 Claims Incurred
- NL-6 Commission
- NL-7 Operating Expenses
- NL-8 Share Capital
- NL-9 Pattern of Shareholding
- NL-9A Pattern of Shareholding-Annexure A
- NL-10 Reserves and Surplus
- NL-11 Borrowings
- NL-12 & 12A Investments
- NL-13 Loans
- NL-14 Fixed Assets
- NL-15 Cash and Bank Balance
- NL-16 Advances & Other Assets
- NL-17 Current Liabilities
- NL-18 Provisions
- NL-19 Misc Expenditure
- NL-20 Analytical Ratios
- NL-21 Related Party Transactions
- NL-22 Receipts & Payment Sch
- NL-23 Statement of Admissible Assets
- NL-24 Statement of Liabilities
- NL-25 Required Solvency Margin
- NL-26 Solvency Margin
- NL-27 Product Information
- NL-28 Investment assets and Accretion of Assets
- NL-29 Debt Securities
- NL-30 Non performing assets
- NL-31 Investment and Investment Income
- NL-32 Down graded Investments
- NL-33 Reinsurance Risk Concentration
- NL-34 Geographical Distribution of Business
- NL-35 Quarterly Business Returns
- NL-36 Business channels
- NL-37 Claims Data
- NL-38 Development of Losses
- NL-39 Ageing of Claims
- NL-41 Office Information
- NL-42 Board of Directors & Management Person
- NL-43 Rural & Social Sector Obligations
- NL-44 Motor Third Party Obligation
- NL-45 Grievance Disposal
- NL-46 Voting Activity disclosure under Stewardship Code
- NL-47 Performance HI PA TI
- NL-48 Health Services
- NL 48-Disclosures on Quantitative and Qualitative Parameters of Health services rendered
- Inhouse FY 2022-23
- Paramount
- Ericson
- Medi Assist
- East West Assist
- Health India
- Vidal
- FHPL
- MD India
- Voting Rights
- Stewardship Policy
FY 2023-24 - Q1
- NL-1 Revenue Account
- NL-2 Profit and Loss Account
- NL-3 Balance Sheet
- NL-4 Premium
- NL-5 Claims Incurred
- NL-6 Commission
- NL-7 Operating Expenses
- NL-8 Share Capital
- NL-9 Pattern of Shareholding
- NL-9A Pattern of Shareholding-Annexure A
- NL-10 Reserves and Surplus
- NL-11 Borrowings
- NL-12 & 12A Investments
- NL-13 Loans
- NL-14 Fixed Assets
- NL-15 Cash and Bank Balance
- NL-16 Advances & Other Assets
- NL-17 Current Liabilities
- NL-18 Provisions
- NL-19 Misc Expenditure
- NL-20 Analytical Ratios
- NL-21 Related Party Transactions
- NL-23 Statement of Admissible Assets
- NL-24 Statement of Liabilities
- NL-25 Required Solvency Margin
- NL-26 Solvency Margin
- NL-27 Product Information
- NL-28 Investment assets and Accretion of Assets
- NL-29 Debt Securities
- NL-30 Non performing assets
- NL-31 Investment and Investment Income
- NL-32 Down graded Investments
- NL-33 Reinsurance Risk Concentration
- NL-34 Geographical Distribution of Business
- NL-35 Quarterly Business Returns
- NL-36 Business channels
- NL-37 Claims Data
- NL-39 Ageing of Claims
- NL-41 Office Information
- NL-42 Board of Directors & Management Person
- NL-43 Rural & Social Sector Obligations
- NL-44 Motor Third Party Obligation
- NL-45 Grievance Disposal
- NL-46 Voting Activity disclosure under Stewardship Code
FY 2023-24 - Q2
- NL-1 Revenue Account
- NL-2 Profit and Loss Account
- NL-3 Balance Sheet
- NL-4 Premium
- NL-5 Claims Incurred
- NL-6 Commission
- NL-7 Operating Expenses
- NL-8 Share Capital
- NL-9 Pattern of Shareholding
- NL-9A Pattern of Shareholding-Annexure A
- NL-10 Reserves and Surplus
- NL-11 Borrowings
- NL-12 & 12A Investments
- NL-13 Loans
- NL-14 Fixed Assets
- NL-15 Cash and Bank Balance
- NL-16 Advances & Other Assets
- NL-17 Current Liabilities
- NL-18 Provisions
- NL-19 Misc Expenditure
- NL-20 Analytical Ratios
- NL-21 Related Party Transactions
- NL-23 Statement of Admissible Assets
- NL-24 Statement of Liabilities
- NL-25 Required Solvency Margin
- NL-26 Solvency Margin
- NL-27 Product Information
- NL-28 Investment assets and Accretion of Assets
- NL-29 Debt Securities
- NL-30 Non performing assets
- NL-31 Investment and Investment Income
- NL-32 Down graded Investments
- NL-33 Reinsurance Risk Concentration
- NL-34 Geographical Distribution of Business
- NL-35 Quarterly Business Returns
- NL-36 Business channels
- NL-37 Claims Data
- NL-39 Ageing of Claims
- NL-41 Office Information
- NL-42 Board of Directors & Management Person
- NL-43 Rural & Social Sector Obligations
- NL-44 Motor Third Party Obligation
- NL-45 Grievance Disposal
- NL-46 Voting Activity disclosure under Stewardship Code
FY 2023-24 - Q3
- NL-1 Revenue Account
- NL-2 Profit and Loss Account
- NL-3 Balance Sheet
- NL-4 Premium
- NL-5 Claims Incurred
- NL-6 Commission
- NL-7 Operating Expenses
- NL-8 Share Capital
- NL-9 Pattern of Shareholding
- NL-9A Pattern of Shareholding-Annexure A
- NL-10 Reserves and Surplus
- NL-11 Borrowings
- NL-12 & 12A Investments
- NL-13 Loans
- NL-14 Fixed Assets
- NL-15 Cash and Bank Balance
- NL-16 Advances & Other Assets
- NL-17 Current Liabilities
- NL-18 Provisions
- NL-19 Misc Expenditure
- NL-20 Analytical Ratios
- NL-21 Related Party Transactions
- NL-23 Statement of Admissible Assets
- NL-24 Statement of Liabilities
- NL-25 Required Solvency Margin
- NL-26 Solvency Margin
- NL-27 Product Information
- NL-28 Investment assets and Accretion of Assets
- NL-29 Debt Securities
- NL-30 Non performing assets
- NL-31 Investment and Investment Income
- NL-32 Down graded Investments
- NL-33 Reinsurance Risk Concentration
- NL-34 Geographical Distribution of Business
- NL-35 Quarterly Business Returns
- NL-36 Business channels
- NL-37 Claims Data
- NL-39 Ageing of Claims
- NL-41 Office Information
- NL-42 Board of Directors & Management Person
- NL-43 Rural & Social Sector Obligations
- NL-44 Motor Third Party Obligation
- NL-45 Grievance Disposal
- NL-46 Voting Activity disclosure under Stewardship Code
FY 2023-24 - Q4
- NL-1 Revenue Account
- NL-2 Profit and Loss Account
- NL-3 Balance Sheet
- NL-4 Premium
- NL-5 Claims Incurred
- NL-6 Commission
- NL-7 Operating Expenses
- NL-8 Share Capital
- NL-9 Pattern of Shareholding
- NL-9A Pattern of Shareholding-Annexure A
- NL-10 Reserves and Surplus
- NL-11 Borrowings
- NL-12 & 12A Investments
- NL-13 Loans
- NL-14 Fixed Assets
- NL-15 Cash and Bank Balance
- NL-16 Advances & Other Assets
- NL-17 Current Liabilities
- NL-18 Provisions
- NL-19 Misc Expenditure
- NL-20 Analytical Ratios
- NL-21 Related Party Transactions
- NL-22 Receipts & Payment Sch
- NL-23 Statement of Admissible Assets
- NL-24 Statement of Liabilities
- NL-25 Required Solvency Margin
- NL-26 Solvency Margin
- NL-27 Product Information
- NL-28 Investment assets and Accretion of Assets
- NL-29 Debt Securities
- NL-30 Non performing assets
- NL-31 Investment and Investment Income
- NL-32 Down graded Investments
- NL-33 Reinsurance Risk Concentration
- NL-34 Geographical Distribution of Business
- NL-35 Quarterly Business Returns
- NL-36 Business channels
- NL-37 Claims Data
- NL-38 Development of Losses
- NL-39 Ageing of Claims
- NL-41 Office Information
- NL-42 Board of Directors & Management Person
- NL-43 Rural & Social Sector Obligations
- NL-44 Motor Third Party Obligation
- NL-45 Grievance Disposal
- NL-46 Voting Activity disclosure under Stewardship Code
- NL-47 Performance HI PA TI
- NL-48 Health Services
- Inhouse FY 2023-24
- Vidal_FY_2023-24
- Volo_FY_2023-24
- Park_FY_2023-24
- Medi Assist_FY_2023-24
- MD India_FY_2023-24
- FHPL_FY_2023-24
- Ericson_FY_2023-24
- Paramount_FY_2023-24
- Health India_FY_2023-24
- GHPL_FY_2023-24
FY 2024-25 - Q1
- NL-1 Revenue Account
- NL-2 Profit and Loss Account
- NL-3 Balance Sheet
- NL-4 Premium
- NL-5 Claims Incurred
- NL-6 Commission
- NL-7 Operating Expenses
- NL-8 Share Capital
- NL-9 Pattern of Shareholding
- NL-9A Pattern of Shareholding-Annexure A
- NL-10 Reserves and Surplus
- NL-11 Borrowings
- NL-12 & 12A Investments
- NL-13 Loans
- NL-14 Fixed Assets
- NL-15 Cash and Bank Balance
- NL-16 Advances & Other Assets
- NL-17 Current Liabilities
- NL-18 Provisions
- NL-19 Misc Expenditure
- NL-20 Analytical Ratios
- NL-21 Related Party Transactions
- NL-23 Statement of Admissible Assets
- NL-24 Statement of Liabilities
- NL-25 Required Solvency Margin
- NL-26 Solvency Margin
- NL-27 Product Information
- NL-28 Investment assets and Accretion of Assets
- NL-29 Debt Securities
- NL-30 Non performing assets
- NL-31 Investment and Investment Income
- NL-32 Down graded Investments
- NL-33 Reinsurance Risk Concentration
- NL-34 Geographical Distribution of Business
- NL-35 Quarterly Business Returns
- NL-36 Business channels
- NL-37 Claims Data
- NL-39 Ageing of Claims
- NL-41 Office Information
- NL-42 Board of Directors & Management Person
- NL-43 Rural & Social Sector Obligations
- NL-44 Motor Third Party Obligation
- NL-45 Grievance Disposal
- NL-46 Voting Activity disclosure under Stewardship Code
FY 2024-25 - Q2
- NL-1 Revenue Account
- NL-2 Profit and Loss Account
- NL-3 Balance Sheet
- NL-4 Premium
- NL-5 Claims Incurred
- NL-6 Commission
- NL-7 Operating Expenses
- NL-8 Share Capital
- NL-9 Pattern of Shareholding
- NL-9A Pattern of Shareholding-Annexure A
- NL-10 Reserves and Surplus
- NL-11 Borrowings
- NL-12 & 12A Investments
- NL-13 Loans
- NL-14 Fixed Assets
- NL-15 Cash and Bank Balance
- NL-16 Advances & Other Assets
- NL-17 Current Liabilities
- NL-18 Provisions
- NL-19 Misc Expenditure
- NL-20 Analytical Ratios
- NL-21 Related Party Transactions
- NL-23 Statement of Admissible Assets
- NL-24 Statement of Liabilities
- NL-25 Required Solvency Margin
- NL-26 Solvency Margin
- NL-27 Product Information
- NL-28 Investment assets and Accretion of Assets
- NL-29 Debt Securities
- NL-30 Non performing assets
- NL-31 Investment and Investment Income
- NL-32 Down graded Investments
- NL-33 Reinsurance Risk Concentration
- NL-34 Geographical Distribution of Business
- NL-35 Quarterly Business Returns
- NL-36 Business channels
- NL-37 Claims Data
- NL-39 Ageing of Claims
- NL-41 Office Information
- NL-42 Board of Directors & Management Person
- NL-43 Rural & Social Sector Obligations
- NL-44 Motor Third Party Obligation
- NL-45 Grievance Disposal
- NL-46 Voting Activity disclosure under Stewardship Code
FY 2024-25 - Q3
- NL-1 Revenue Account
- NL-2 Profit and Loss Account
- NL-3 Balance Sheet
- NL-4 Premium
- NL-5 Claims Incurred
- NL-6 Commission
- NL-7 Operating Expenses
- NL-8 Share Capital
- NL-9 Pattern of Shareholding
- NL-9A Pattern of Shareholding-Annexure A
- NL-10 Reserves and Surplus
- NL-11 Borrowings
- NL-12 & 12A Investments
- NL-13 Loans
- NL-14 Fixed Assets
- NL-15 Cash and Bank Balance
- NL-16 Advances & Other Assets
- NL-17 Current Liabilities
- NL-18 Provisions
- NL-19 Misc Expenditure
- NL-20 Analytical Ratios
- NL-21 Related Party Transactions
- NL-23 Statement of Admissible Assets
- NL-24 Statement of Liabilities
- NL-25 Required Solvency Margin
- NL-26 Solvency Margin
- NL-27 Product Information
- NL-28 Investment assets and Accretion of Assets
- NL-29 Debt Securities
- NL-30 Non performing assets
- NL-31 Investment and Investment Income
- NL-32 Down graded Investments
- NL-33 Reinsurance Risk Concentration
- NL-34 Geographical Distribution of Business
- NL-35 Quarterly Business Returns
- NL-36 Business channels
- NL-37 Claims Data
- NL-39 Ageing of Claims
- NL-41 Office Information
- NL-42 Board of Directors & Management Person
- NL-43 Rural & Social Sector Obligations
- NL-44 Motor Third Party Obligation
- NL-45 Grievance Disposal
- NL-46 Voting Activity disclosure under Stewardship Code
- Voting Rights
- Stewardship Policy
FY 2024-25 - Q4
- NL-1 Revenue Account
- NL-2 Profit and Loss Account
- NL-3 Balance Sheet
- NL-4 Premium
- NL-5 Claims Incurred
- NL-6 Commission
- NL-7 Operating Expenses
- NL-8 Share Capital
- NL-9 Pattern of Shareholding
- NL-9A Pattern of Shareholding-Annexure A
- NL-10 Reserves and Surplus
- NL-11 Borrowings
- NL-12 & 12A Investments
- NL-13 Loans
- NL-14 Fixed Assets
- NL-15 Cash and Bank Balance
- NL-16 Advances & Other Assets
- NL-17 Current Liabilities
- NL-18 Provisions
- NL-19 Misc Expenditure
- NL-20 Analytical Ratios
- NL-21 Related Party Transactions
- NL-22 Receipts & Payment Sch
- NL-23 Statement of Admissible Assets
- NL-24 Statement of Liabilities
- NL-25 Required Solvency Margin
- NL-26 Solvency Margin
- NL-27 Product Information
- NL-28 Investment assets and Accretion of Assets
- NL-29 Debt Securities
- NL-30 Non performing assets
- NL-31 Investment and Investment Income
- NL-32 Down graded Investments
- NL-34 Geographical Distribution of Business
- NL-33 Reinsurance Risk Concentration
- NL-35 Quarterly Business Returns
- NL-36 Business channels
- NL-37 Claims Data
- NL-38 Development of Losses
- NL-39 Ageing of Claims
- NL-41 Office Information
- NL-42 Board of Directors & Management Person
- NL-43 Rural & Social Sector Obligations
- NL-44 Motor Third Party Obligation
- NL-45 Grievance Disposal
- NL-46 Voting Activity disclosure under Stewardship Code
- NL-47 Performance HI PA TI
- NL-48 Health Services
- MD_India_FY2024-25
- Vidal_FY_2024-25
- Volo_FY_2024-25
- Park_FY_2024-25
- Medi Assist_FY_2024-25
- FHPL_FY_2024-25
- Ericson_FY_2024-25
- Paramount_FY_2024-25
- Health India_FY_2024-25
- GHPL_FY_2023-24
- Stewardship policy
FY 2025-26 - Q1
- NL-1 Revenue Account
- NL-2 Profit and Loss Account
- NL-3 Balance Sheet
- NL-4 Premium
- NL-5 Claims Incurred
- NL-6 Commission
- NL-7 Operating Expenses
- NL-8 Share Capital
- NL-9 Pattern of Shareholding
- NL-9A Pattern of Shareholding-Annexure A
- NL-10 Reserves and Surplus
- NL-11 Borrowings
- NL-12 & 12A Investments
- NL-13 Loans
- NL-14 Fixed Assets
- NL-15 Cash and Bank Balance
- NL-16 Advances & Other Assets
- NL-17 Current Liabilities
- NL-18 Provisions
- NL-19 Misc Expenditure
- NL-20 Analytical Ratios
- NL-21 Related Party Transactions
- NL-23 Statement of Admissible Assets
- NL-24 Statement of Liabilities
- NL-25 Required Solvency Margin
- NL-26 Solvency Margin
- NL-27 Product Information
- NL-28 Investment assets and Accretion of Assets
- NL-29 Debt Securities
- NL-30 Non performing assets
- NL-31 Investment and Investment Income
- NL-32 Down graded Investments
- NL-33 Reinsurance Risk Concentration
- NL-34 Geographical Distribution of Business
- NL-35 Quarterly Business Returns
- NL-36 Business channels
- NL-37 Claims Data
- NL-39 Ageing of Claims
- NL-41 Office Information
- NL-42 Board of Directors & Management Person
- NL-43 Rural & Social Sector Obligations
- NL-44 Motor Third Party Obligation
- NL-45 Grievance Disposal
- NL-46 Voting Activity disclosure under Stewardship Code
FY 2025-26 - Q2
- NL-1 Revenue Account
- NL-2 Profit and Loss Account
- NL-3 Balance Sheet
- NL-4 Premium
- NL-5 Claims Incurred
- NL-6 Commission
- NL-7 Operating Expenses
- NL-8 Share Capital
- NL-9 Pattern of Shareholding
- NL-9A Pattern of Shareholding-Annexure A
- NL-10 Reserves and Surplus
- NL-11 Borrowings
- NL-12 & 12A Investments
- NL-13 Loans
- NL-14 Fixed Assets
- NL-15 Cash and Bank Balance
- NL-16 Advances & Other Assets
- NL-17 Current Liabilities
- NL-18 Provisions
- NL-19 Misc Expenditure
- NL-20 Analytical Ratios
- NL-21 Related Party Transactions
- NL-23 Statement of Admissible Assets
- NL-24 Statement of Liabilities
- NL-25 Required Solvency Margin
- NL-26 Solvency Margin
- NL-27 Product Information
- NL-28 Investment assets and Accretion of Assets
- NL-29 Debt Securities
- NL-30 Non performing assets
- NL-31 Investment and Investment Income
- NL-32 Down graded Investments
- NL-33 Reinsurance Risk Concentration
- NL-34 Geographical Distribution of Business
- NL-35 Quarterly Business Returns
- NL-36 Business channels
- NL-37 Claims Data
- NL-39 Ageing of Claims
- NL-41 Office Information
- NL-42 Board of Directors & Management Person
- NL-43 Rural & Social Sector Obligations
- NL-44 Motor Third Party Obligation
- NL-45 Grievance Disposal
- NL-46 Voting Activity disclosure under Stewardship Code
FY 2025-26 - Q3
- NL-1 Revenue Account
- NL-2 Profit and Loss Account
- NL-3 Balance Sheet
- NL-4 Premium
- NL-5 Claims Incurred
- NL-6 Commission
- NL-7 Operating Expenses
- NL-8 Share Capital
- NL-9 Pattern of Shareholding
- NL-9A Pattern of Shareholding-Annexure A
- NL-10 Reserves and Surplus
- NL-11 Borrowings
- NL-12 & 12A Investments
- NL-13 Loans
- NL-14 Fixed Assets
- NL-15 Cash and Bank Balance
- NL-16 Advances & Other Assets
- NL-17 Current Liabilities
- NL-18 Provisions
- NL-19 Misc Expenditure
- NL-20 Analytical Ratios
- NL-21 Related Party Transactions
- NL-23 Statement of Admissible Assets
- NL-24 Statement of Liabilities
- NL-25 Required Solvency Margin
- NL-26 Solvency Margin
- NL-27 Product Information
- NL-28 Investment assets and Accretion of Assets
- NL-29 Debt Securities
- NL-30 Non performing assets
- NL-31 Investment and Investment Income
- NL-32 Down graded Investments
- NL-33 Reinsurance Risk Concentration
- NL-34 Geographical Distribution of Business
- NL-35 Quarterly Business Returns
- NL-36 Business channels
- NL-37 Claims Data
- NL-39 Ageing of Claims
- NL-41 Office Information
- NL-42 Board of Directors & Management Person
- NL-43 Rural & Social Sector Obligations
- NL-44 Motor Third Party Obligation
- NL-45 Grievance Disposal
- NL-46 Voting Activity disclosure under Stewardship Code